Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.

Abstract excerpt

Human leukocyte antigen B (HLA-B) is responsible for presenting peptides to immune cells and plays a critical role in normal immune recognition of pathogens. A variant allele, HLA-B*57:01, is associated with increased risk of a hypersensitivity reaction to the anti-HIV drug abacavir. In the absence of genetic prescreening, hypersensitivity affects ~6% of patients and can be life-threatening with repeated dosing....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dideoxynucleosides
• Share to Drug-Induced Adverse Reactions